For the quarter ending 2025-10-03, ENOV had -$10,457K decrease in cash & cash equivalents over the period. $29,085K in free cash flow.
| Cash Flow | 2025-10-03 | 2025-07-04 |
|---|---|---|
| Net income (loss) | -570,913 | -92,253 |
| Depreciation and amortization | 74,380 | 142,986 |
| Impairment of assets | 0 | - |
| Impairment of goodwill | 548,442 | - |
| Impairment of assets | - | 0 |
| Stock-based compensation expense | 8,734 | 16,075 |
| Non-cash interest expense | 1,917 | 3,203 |
| Fair value loss (gain) on contingent acquisition shares | 0 | 1,787 |
| Loss on currency hedges | 0 | 0 |
| Deferred income tax expense (benefit) | 3,108 | -3,673 |
| Loss (gain) on sale of property, plant and equipment | -281 | -848 |
| Trade receivables, net | -20,807 | 20,824 |
| Inventories, net | -24,129 | 57,282 |
| Accounts payable | -12,816 | 23,161 |
| Other operating assets and liabilities | 15,493 | -32,145 |
| Net cash provided by operating activities | 82,576 | 46,173 |
| Purchases of property, plant and equipment and intangibles | 53,491 | 87,631 |
| Payments for acquisitions, net of cash received, and investments | 2,569 | 24,290 |
| Cash received upon settlement of derivatives | 0 | 1,601 |
| Net cash used in investing activities | -56,060 | -110,320 |
| Proceeds from borrowings on term credit facility | 0 | 0 |
| Repayments of borrowings under term credit facility | 5,000 | 10,000 |
| Proceeds from borrowings on revolving credit facilities and other | 50,000 | 127,000 |
| Repayments of borrowings on revolving credit facilities and other | 81,867 | 54,995 |
| Payment of debt issuance costs | 0 | 0 |
| Payments of tax withholding for stock-based awards | 57 | 3,447 |
| Proceeds from issuance of common stock, net | 189 | 1,129 |
| Deferred consideration payments and other | -172 | -2,265 |
| Net cash provided by financing activities | -36,907 | 57,422 |
| Effect of foreign exchange rates on cash and cash equivalents | -66 | 2,632 |
| Decrease in cash and cash equivalents | -10,457 | -4,093 |
| Cash and cash equivalents at beginning of period | 48,167 | - |
| Cash and cash equivalents at end of period | 33,617 | - |
Enovis CORP (ENOV)
Enovis CORP (ENOV)